v3 Template
N

Nocion Therapeutics

Biopharmaceutical ~440 employees
Founded
--
Employees (Est.)
~440
22 leaders known
Total Funding
$132.0M
Funding Rounds
2
Last Funding
2024-04-02

About Nocion Therapeutics

Nocion Therapeutics is a biopharmaceutical company focused on revolutionizing the treatment of conditions arising from neurogenic inflammation. They develop 'nocions,' a novel therapy that selectively targets actively firing nociceptors to provide targeted, robust, and sustained relief for conditions such as cough, itch, pain, and inflammation.

Products & Services

Nocions:A new kind of therapy that selectively affects inflamed nociceptors to treat conditions like cough, itch, pain, and inflammation by inhibiting sodium channels for long-acting relief.
Lead Compound for Cough:A lead product targeting chronic idiopathic cough and other respiratory conditions, with potential applications across multiple indications including pulmonology, gynecology/urology, pain, dermatology, gastroenterology, and ophthalmology.

Specialties

Neurogenic Inflammation Treatment Nociceptor-Targeted Therapies Sodium Channel Blockers Chronic Cough Treatment Pain Management Inflammation Relief

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B
A: 70000000
MR: -
FA: $70M
FAN: 70000000
D: 2024-04-02
FD: 2024-04-02
3 investors
2 RT: Series B
T: -
FT: Series B
A: 62000000
MR: -
FA: $62 million
FAN: 62000000
D: 2024-03-04
FD: 2024-03-04
7 investors
Series B Latest
2024-04-02
$70.0M
3 investors (Pro only)
Series B 2024-03-04
$62.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Matthew Frankel

Chief Medical Officer

R

Richard P. Batycky

President and Chief Executive Officer

P

Peter Courossi

Acting Chief Financial Officer

J

James L. Ellis

Chief Scientific Officer

J

Joan E. Shaw

Senior Vice President, Clinical Operations

C

Clifford Woolf

Professor in Neurology and Neurobiology

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Nocion Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~440 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro